Question 1

Has Yamah Mator received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,968 in general payments to Yamah Mator across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Yamah Mator did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Yamah Mator come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	24	$389
Corium, LLC	11	$244
Neurocrine Biosciences, Inc.	10	$212
Lundbeck LLC	8	$164
Teva Pharmaceuticals USA, Inc.	6	$138
Otsuka America Pharmaceutical, Inc.	7	$132
Alkermes, Inc.	5	$113
Vanda Pharmaceuticals Inc.	4	$104
Bausch Health US, LLC	4	$91
Ironshore Pharmaceuticals Inc.	4	$89
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$63
Axsome Therapeutics, Inc.	2	$47
Takeda Pharmaceuticals U.S.A., Inc.	2	$45
Lilly USA, LLC	2	$33
E.r. Squibb & Sons, L.L.C.	1	$32
Johnson & Johnson	1	$21
Noven Therapeutics, LLC	1	$18
Almatica Pharma LLC	1	$18
Vertical Pharmaceuticals, LLC	1	$14

Yamah Mator

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatric/mental health in Media